Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life

A. Y. Finlay*, M. S. Salek, D. Abeni, L. Tomás-Aragonés, O. D. van Cranenburgh, A. W.M. Evers, G. B.E. Jemec, D. Linder, L. Manolache, S. E. Marrón, C. A.C. Prinsen, P. Susitaival, P. V. Chernyshov, the EADV Task Force on Quality of Life

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review


The aim of this study was to describe the many ways in which quality of life (QoL) measurement may potentially be advantageous in routine clinical dermatology practice. Thirteen members of the EADV Task Force on Quality of Life, eight dermatologists, three health psychologists, one epidemiologist and one pharmacoepidemiologist, independently listed all of the ways they thought this may be advantageous. A total of 108 different ways of using QoL information in clinical practice were suggested (median per participant = 8, range = 4–15), and were classified into 20 descriptive groups. These were sorted into the following five categories: inform clinical decisions, clinician–patient communication, awareness of skin disease burden, informing the consultation and clinical service administration. The wide range of potential benefits identified may not only encourage clinicians to use these measures but also highlights many areas requiring evidence to establish the true value of routine use of QoL measures.

Original languageEnglish
Pages (from-to)424-431
Number of pages8
JournalJournal of the European Academy of Dermatology and Venereology
Issue number3
Publication statusPublished - 1 Mar 2017

Cite this